BioCryst Pharmaceuticals, Inc. (BCRX)

8.17 +0.05 (+0.62%) USD  |  NASDAQ  |  Oct 02, 16:00
8.15 -0.02 (-0.24%) After-Hours: 20:00
More

BioCryst Pharmaceuticals EPS LT Growth Estimates

EPS LT Growth Estimates Chart

View EPS LT Growth Estimates for BCRX.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00

Historical EPS LT Growth Estimates Data

View and export this data back to . Start Trial.
Date Value

EPS LT Growth Estimates Range, Past 5 Years

View EPS LT Growth Estimates Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

EPS LT Growth Estimates Benchmarks

View EPS LT Growth Estimates Benchmarks
Start Trial
Amgen, Inc. Upgrade
Halozyme Therapeutics, Inc. Upgrade
Neurocrine Biosciences, Inc. Upgrade
Vertex Pharmaceuticals, Inc. Upgrade
Agenus, Inc. --